Open main menu
Home
Random
Recent changes
Special pages
Community portal
Preferences
About Wikipedia
Disclaimers
Incubator escapee wiki
Search
User menu
Talk
Dark mode
Contributions
Create account
Log in
Editing
Cancer vaccine
(section)
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
== Antigen candidates == [[Tumor antigen]]s have been divided into two categories: ''shared'' tumor antigens; and ''unique'' tumor antigens. Shared antigens are expressed by many tumors. Unique tumor antigens result from mutations induced through physical or chemical carcinogens; they are therefore expressed only by individual tumors. In one approach, vaccines contain whole tumor cells, though these vaccines have been less effective in eliciting immune responses in spontaneous cancer models. Defined tumor antigens decrease the risk of autoimmunity, but because the immune response is directed to a single [[epitope]], tumors can evade destruction through antigen loss variance. A process called "epitope spreading" or "provoked immunity" may mitigate this weakness, as sometimes an immune response to a single antigen can lead to immunity against other antigens on the same tumor.<ref name="Pejawar-Gaddy S 2008"/> For example, since [[Hsp70]] plays an important role in the [[Antigen presentation|presentation of antigens]] of destroyed cells including cancer cells,<ref>{{cite journal | vauthors = Nishikawa M, Takemoto S, Takakura Y | title = Heat shock protein derivatives for delivery of antigens to antigen presenting cells | journal = International Journal of Pharmaceutics | volume = 354 | issue = 1β2 | pages = 23β27 | date = April 2008 | pmid = 17980980 | doi = 10.1016/j.ijpharm.2007.09.030 | series = Special Issue in Honor of Prof. Tsuneji Nagai }}</ref> this protein may be used as an effective adjuvant in the development of antitumor vaccines.<ref>{{cite journal | vauthors = Savvateeva LV, Schwartz AM, Gorshkova LB, Gorokhovets NV, Makarov VA, Reddy VP, Aliev G, Zamyatnin AA | display-authors = 6 | title = Prophylactic Admission of an In Vitro Reconstructed Complexes of Human Recombinant Heat Shock Proteins and Melanoma Antigenic Peptides Activates Anti-Melanoma Responses in Mice | journal = Current Molecular Medicine | volume = 15 | issue = 5 | pages = 462β468 | date = 2015-01-01 | pmid = 26122656 | doi = 10.2174/1566524015666150630125024 }}</ref>
Edit summary
(Briefly describe your changes)
By publishing changes, you agree to the
Terms of Use
, and you irrevocably agree to release your contribution under the
CC BY-SA 4.0 License
and the
GFDL
. You agree that a hyperlink or URL is sufficient attribution under the Creative Commons license.
Cancel
Editing help
(opens in new window)